Your Cart ( 1 Item )

• Randomized, Placebo- and Active-Controlled Crossover Study of the Safety and Efficacy of THVD-102, a Fixed-dose Combination of Oxybutynin and Pilocarpine, in Subjects With Primary Focal Hyperhidrosis
  February 2017 | Volume 16 | Issue 2 | Original Article | 127 | Copyright © February 2017
  David M. Pariser MD FACP FAAD,^a Janakan Krishnaraja MD,^b Thomas M. Tremblay RN,d R. Michael Rubison PhD,^c Ted W. Love MD,^d and Benjamin F. McGraw III PharmD^d
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs